Skip to content

Beacon Tip Sizing Catheter and Slip-Cath Beacon Tip Catheter Study

Beacon Tip Sizing Catheter and Slip-Cath Beacon Tip Catheter Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06986954
Enrollment
816
Registered
2025-05-23
Start date
2025-04-20
Completion date
2026-03-04
Last updated
2026-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bleed Intracranial, Pseudoaneurysm, Stenosis, Stroke, TIA, Vascular Malformation

Keywords

Catheter, Beacon, Diagnostic imaging, Device sizing, Beacon tip slip cath

Brief summary

This prospective observational post-market clinical study will collect data in the United States to primarily support the re-launch of the re-designed Beacon Tip Sizing Catheter and Slip-Catheter Beacon Tip Catheter & Shuttle Select Slip-Catheter (Visceral and Cerbral) for a Conformité Européenne (CE) Mark application in the European Union (EU). Additionally, the data from this study may be used to support regulatory approval in other countries/regions. The purpose of this clinical study is to evaluate the safety and performance of these catheters in accordance with the Intended Use through the end of index procedure, and through 30 days post procedure, (as applicable as data is available) to ensure an acceptable benefit:risk ratio.

Interventions

DEVICEBeacon Tip Catheters

Indicated for use in angiographic procedures by physicians trained and experienced in angiographic techniques. Standard techniques for placement of vascular access sheaths, angiographic catheters, and wire guides should be employed. Beacon Tip Sizing Catheters have marker bands that can be used for anatomical measurements.

Sponsors

Cook Research Incorporated
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* A patient is deemed suitable for inclusion in this study if the patient undergoes a procedure using an applicable Beacon Tip Catheter.

Exclusion criteria

* Patient or his/her legally authorized representative objects to collection and processing of his/her data, or not willing to accept the use of an Informed Consent waiver or the data protection notice (if utilized).

Design outcomes

Primary

MeasureTime frameDescription
Successful navigation to the intended locationDuration of the procedure (approx. 1 hour)The primary performance outcome is successful navigation to the intended location The percent of successful navigation to the intended location
Successful intended useDuration of the procedure (approx. 1 hour)Successful intended use (e.g. release of contrast agent (if applicable), successful anatomical sizing (if applicable)), after successful navigation to the intended location
Freedom from catheter-related major complicationsup to 30 daysThe primary safety outcome is freedom from catheter-related major complications. Major complications are defined as those that: * Require therapy, minor hospitalization (\<48 hours); * Require major therapy, unplanned increase in level of care, prolonged hospitalization; * Have permanent adverse sequelae; or result in death. The percent of patients with freedom from catheter-related major complications

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 7, 2026